✦ LIBER ✦

Introduction: Epitope mimicry as a component cause of autoimmune disease

✍ Scribed by J. M. Davies *

Book ID: 105740501
Publisher: Springer
Year: 2000
Tongue: English
Weight: 47 KB
Volume: 57
Category: Article
ISSN: 1420-682X
DOI: 10.1007/pl00000713

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Current cases in which epitope mimicry i

Current cases in which epitope mimicry is considered a component cause of autoimmune disease: Guillain-Barré syndrome

✍ N. Yuki 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 91 KB

Current cases in which epitope mimicry i

Current cases in which epitope mimicry is considered as a component cause of autoimmune disease: immune-mediated (type 1) diabetes

✍ A. Kukreja; N. K. Maclaren * 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 81 KB

Autoimmunity due to molecular mimicry as

Autoimmunity due to molecular mimicry as a cause of neurological disease

✍ Stuart, John M.; Levin, Michael C.; Lee, Sang Min; Kalume, Franck; Morcos, Yvett 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 596 KB

Molecular Mimicry as a Mechanism of Auto

Molecular Mimicry as a Mechanism of Autoimmune Disease

✍ Matthew F. Cusick; Jane E. Libbey; Robert S. Fujinami 📂 Article 📅 2011 🏛 Humana Press Inc 🌐 English ⚖ 194 KB

Molecular mimicry as a therapeutic appro

Molecular mimicry as a therapeutic approach for autoimmune disease: oral treatment of patients with an MHC-peptide crossreactive with autoantigen

✍ S.R. Thurau; M. Dietrichs-Möhring; H. Fricke; G. Wildner 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 365 KB

Antiidiotypic PTH antibodies as a cause

Antiidiotypic PTH antibodies as a cause of elevated immunoreactive parathyroid hormone in idiopathic hypoparathyroidism, a second case: Another manifestation of autoimmune endocrine disease?

✍ Aidan McElduff; Martin Lackmann; Margaret Wilkinson 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 638 KB

A 69-year-old man became hypocalcemic under medical observation. The hypocalcemia occurred in the presence of circulating immunoreactive parathyroid hormone (PTH). Common causes of secondary hyperparathyroidism were excluded, as was PTH resistance using PTH infusions. The immunoreactive PTH was exam